|
The Canadian Bioceutical Corporation Applies to Convert Debt Into Equity
Baystreet.ca Therefore, this debt conversion would provide for the issuance of 3,086,621 common shares issued from BCC’s treasury and an additional 846,155 common share purchase warrants (as described above). No Insiders are expected to be created as a result of … |
